TYVASO: payments to doctors
Payments that named TYVASO as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $6.5M
- Providers
- 10,961
- Transactions
- 49,349
- Average per transaction
- $133
The per-transaction average — $133 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 10,961 providers the average total is $597, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| United Therapeutics Corporation | $6,543,205 | 100.0% |